1. Home
  2. DMRC vs MDXH Comparison

DMRC vs MDXH Comparison

Compare DMRC & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Digimarc Corporation

DMRC

Digimarc Corporation

HOLD

Current Price

$8.61

Market Cap

170.6M

Sector

Technology

ML Signal

HOLD

Logo MDxHealth SA

MDXH

MDxHealth SA

HOLD

Current Price

$2.01

Market Cap

149.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
DMRC
MDXH
Founded
2008
2003
Country
United States
Belgium
Employees
N/A
N/A
Industry
EDP Services
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
170.6M
149.0M
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
DMRC
MDXH
Price
$8.61
$2.01
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$10.00
$7.67
AVG Volume (30 Days)
158.5K
177.2K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
18.58
N/A
EPS
N/A
N/A
Revenue
$25,213,000.00
N/A
Revenue This Year
N/A
$30.78
Revenue Next Year
N/A
$18.31
P/E Ratio
N/A
N/A
Revenue Growth
15.69
N/A
52 Week Low
$4.07
$1.76
52 Week High
$14.64
$5.33

Technical Indicators

Market Signals
Indicator
DMRC
MDXH
Relative Strength Index (RSI) 71.47 34.89
Support Level $7.82 $1.96
Resistance Level $8.93 $2.37
Average True Range (ATR) 0.56 0.12
MACD 0.08 0.03
Stochastic Oscillator 98.12 14.29

Price Performance

Historical Comparison
DMRC
MDXH

About DMRC Digimarc Corporation

Digimarc Corp is engaged in digital watermarking technologies. The Digimarc Illuminate platform is a distinctive software as a service (SaaS) cloud-based platform for digital connectivity that provides the tools for the application of digital watermarks and dynamic Quick Response (QR) codes, software (digital twins) that enables various systems and devices to interact with those data carriers and a centralized platform for capturing insights about digital interactions and automating activities based on that information. The company generates revenue through commercial and government applications of its technology. The company derives its revenue from software development services, subscriptions for products and related services, and licensing of patents.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Share on Social Networks: